ESMC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ESMC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Escalon Medical's Average Total Inventories for the three months ended in Dec. 2023 was $1.46 Mil. Escalon Medical's Cost of Goods Sold for the three months ended in Dec. 2023 was $1.61 Mil. Hence, Escalon Medical's Days Inventory for the three months ended in Dec. 2023 was 83.05.
The historical rank and industry rank for Escalon Medical's Days Inventory or its related term are showing as below:
During the past 13 years, Escalon Medical's highest Days Inventory was 138.21. The lowest was 86.96. And the median was 124.13.
Escalon Medical's Days Inventory declined from Dec. 2022 (91.17) to Dec. 2023 (83.05).
Inventory Turnover measures how fast the company turns over its inventory within a year. Escalon Medical's Inventory Turnover for the three months ended in Dec. 2023 was 1.10.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Escalon Medical's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.51.
The historical data trend for Escalon Medical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Escalon Medical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Escalon Medical's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Escalon Medical's Days Inventory for the fiscal year that ended in Jun. 2023 is calculated as
Days Inventory (A: Jun. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Jun. 2022 ) | + | Total Inventories (A: Jun. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Jun. 2023 ) | * | Days in Period |
= | ( (1.604 | + | 1.588) | / | 2 ) | / | 6.699 | * | 365 |
= | 1.596 | / | 6.699 | * | 365 | ||||
= | 86.96 |
Escalon Medical's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (1.519 | + | 1.408) | / | 2 ) | / | 1.608 | * | 365 / 4 |
= | 1.4635 | / | 1.608 | * | 365 / 4 | ||||
= | 83.05 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical (OTCPK:ESMC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Escalon Medical's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 1.608 | / | 1.4635 | |
= | 1.10 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Escalon Medical's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 1.4635 | / | 2.869 | |
= | 0.51 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Escalon Medical's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
David James Jacovini | director | 120 PINE STREET, PHILADELPHIA PA 19106 |
John Dogum | director | 1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103 |
Richard J Depiano | director | 435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087 |
Lisa A Napolitano | director | 351 EAST CONESTOGA ROAD, WAYNE PA 19087 |
C Sean Closkey | director | 1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103 |
C Todd Trusk | director | 1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301 |
Robert Michael O'connor | officer: Chief Financial Officer | 53 SORREL RUN, MT. LAUREL NJ 08054 |
Anthony J Coppola | director | 1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205 |
Federman Jay L Md | director | 501 N. ESSEX AVENUE, NARBERTH PA 19072 |
Kwan William L G | director | 351 EAST CONESTOGA ROAD, WAYNE PA 19087 |
Mark Wallace | officer: Chief Operating Officer | 565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087 |
Fred G Choate | director | 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080 |
Depiano Richard J Jr | officer: President | 575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087 |
Berkowitz David | officer: Principal Accounting Officer | 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087 |
Mark H Karsch | officer: CFO | 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087 |
From GuruFocus
By gurufocus 10qk • 11-16-2009
By gurufocus • 02-18-2009
By gurufocus 10qk • 10-12-2010
By gurufocus • 05-15-2009
By gurufocus 10qk • 05-20-2010
By gurufocus 10qk • 11-15-2010
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.